HomeCompareAMVMF vs MRK

AMVMF vs MRK: Dividend Comparison 2026

AMVMF yields 1.12% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $27.0K in total portfolio value
10 years
AMVMF
AMVMF
● Live price
1.12%
Share price
$40.65
Annual div
$0.46
5Y div CAGR
33.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$2,840.74
Full AMVMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — AMVMF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMVMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMVMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMVMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMVMF
Annual income on $10K today (after 15% tax)
$95.56/yr
After 10yr DRIP, annual income (after tax)
$2,414.63/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $6,182.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMVMF + MRK for your $10,000?

AMVMF: 50%MRK: 50%
100% MRK50/50100% AMVMF
Portfolio after 10yr
$44.2K
Annual income
$6,477.26/yr
Blended yield
14.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AMVMF
No analyst data
Altman Z
1.6
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMVMF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMVMFMRK
Forward yield1.12%2.81%
Annual dividend / share$0.46$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.4%32.7%
Portfolio after 10y$30.7K$57.7K
Annual income after 10y$2,840.74$10,113.78
Total dividends collected$9.4K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMVMF vs MRK ($10,000, DRIP)

YearAMVMF PortfolioAMVMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,850$149.97$11,213$373.04$363.00MRK
2$11,812$202.87$12,667$512.06$855.00MRK
3$12,915$275.35$14,439$708.14$1.5KMRK
4$14,194$375.32$16,640$988.16$2.4KMRK
5$15,702$514.28$19,432$1,394.07$3.7KMRK
6$17,510$709.28$23,057$1,992.90$5.5KMRK
7$19,722$986.13$27,889$2,894.79$8.2KMRK
8$22,487$1,384.74$34,518$4,286.29$12.0KMRK
9$26,030$1,968.45$43,912$6,494.35$17.9KMRK
10$30,693$2,840.74$57,714$10,113.78$27.0KMRK

AMVMF vs MRK: Complete Analysis 2026

AMVMFStock

AMG Critical Materials NV engages in the manufacture and market of specialty metals and metallurgical vacuum furnace systems and provision of engineering services. It operates through the following segments: AGM Clean Energy Materials, AGM Critical Minerals, and AGM Critical Materials Technologies. The AGM Clean Energy Materials segment combines recycling and mining operations, producing materials for infrastructure, and energy storage solutions while reducing the CO2 footprint of both suppliers and customers. The AGM Critical Minerals segment consists of mineral processing operations in graphite, silicon metal, and antimony. The AGM Critical Materials Technologies segment refers to vacuum furnace technology line with high-purity materials serving global leaders in the aerospace sector. The company was founded by Heinz C. Schimmelbusch on November 21, 2006 and is headquartered in Amsterdam, the Netherlands.

Full AMVMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AMVMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMVMF vs SCHDAMVMF vs JEPIAMVMF vs OAMVMF vs KOAMVMF vs MAINAMVMF vs JNJAMVMF vs ABBVAMVMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.